甲氨蝶呤聯(lián)合米非司酮口服治療方案在未破裂型異位妊娠治療中的應(yīng)用效果

打開文本圖片集

【摘要】目的：探討在未破裂型異位妊娠患者的臨床治療中，不同甲氨蝶呤聯(lián)合米非司酮口服治療方案的臨床效果。方法：選取我院接診未破裂型異位妊娠患者64例，隨機(jī)分為A組與B組，兩組分別采取甲氨蝶呤小劑量多次給藥以及甲氨蝶呤單次給藥，同時(shí)聯(lián)合口服米非司酮治療，對(duì)比兩組成功率及不良反應(yīng)。結(jié)果：A組、B組臨床治療成功率分別為87.50%、93.75%，差異無統(tǒng)計(jì)學(xué)意義（P>0.05）；A組、B組不良反應(yīng)發(fā)生率分別為12.50%、3.13%，差異有統(tǒng)計(jì)學(xué)意義（P

【關(guān)鍵詞】未破裂型異位妊娠；甲氨蝶呤；米非司酮

Efficacy of methotrexate combined with mifepristone in the treatment of unruptured ectopic pregnancy

LIU Jing

Dezhou United Hospital of Shandong， Dezhou， Shandong 253000， China

【Abstract】Objective：To investigate the clinical effects of different oral treatment regiments of methotrexate combined with mifepristone in the clinical treatment of unruptured ectopic pregnancy.Methods： A total of 64 patients with unruptured ectopic pregnancy admitted to our hospital were randomly divided into group A and group B.The two groups were treated with methotrexate in multiple times with low dose and methotrexate in a single time，combined with oral mifepristone，respectively，and the success rate and adverse reactions of the two groups were compared.Results：The success rate of clinical treatment in group A and group B were 87.50% and 93.75%，respectively，with no statistical significance（P>0.05）；The incidence of adverse reactions in group A and group B were 12.50% and 3.13%，respectively，and the difference was statistically significant （P

【Key Words】Unruptured ectopic pregnancy； Methotrexate； Mifepristone

異位妊娠是指孕卵著床發(fā)育在子宮腔以外的異常妊娠過程。（剩余4170字）